Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.

Related Videos

October 23, 2018

Best Practices in Oncology Biomarker Testing

Drs. Goeffrey Oxnard and Lauren Ritterhouse review the best practices to improve efficiencies in biomarker testing, including effective communication among the healthcare team, the pathologist, and the patient, as well as expediting processing in the pathology laboratory.

July 29, 2015

How Does the Precision Medicine Revolution Affect Cancer Care?

Dr. Alex Adjei shares an example of how precision medicine has drastically improved the quality of life for many cancer patients, but stresses the need to find more and better approaches to treating various cancer types.